CANQF

Canaquest Medical (PK) Stock Price

0.13
0.00 (0.0%)
0.13
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Small Cap Pro
Monthly Subscription
for only
$49.05
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Canaquest Medical Corporation (PK) CANQF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.13 16:00:00
Open Price Low Price High Price Close Price Previous Close
0.13 0.13
Bid Price Ask Price Spread News
0.05 0.13 0.08 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.13 USD

Canaquest Medical (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.62M 20.14M 4.35M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
382.00 $ - 0.00% - -

more financials information »

Canaquest Medical (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CANQF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.120.130.120.12193463,4670.018.33%
1 Month0.120.130.06210.08428665,4750.018.33%
3 Months0.130.160.060.10804624,3600.000.0%
6 Months0.190.220.060.12458294,033-0.06-31.58%
1 Year0.220.420.060.17310614,004-0.09-40.91%
3 Years0.170.420.03080.16176334,833-0.04-23.53%
5 Years0.170.420.03080.16176334,833-0.04-23.53%

Canaquest Medical (PK) Description

CanaQuest, a Life Science/Pharmaceutical Company, developed Mentanine(R), Omega3 compounds + CBD pharma grade isolate, for mental health issues inside the Central Nervous System by crossing the Blood Brain Barrier (10+ times efficacy, reduced dosage). There was a reduction of inflammation which could be applicable for pain management as well. The Company is working with consultants and has mapped out the regulatory approval pathway for a Drug Identification Number for epilepsy, including initiating human trials, with the US - FDA and Health Canada. Subsidiary, ADC BioMedical Corp, was awarded a Health Canada licence, to sell cannabis and cannabinoid products for Medical purposes.


Your Recent History
USOTC
CANQF
Canaquest ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.